These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24287382)

  • 1. Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.
    Murphy-Benenato K; Wang H; McGuire HM; Davis HE; Gao N; Prince DB; Jahic H; Stokes SS; Boriack-Sjodin PA
    Bioorg Med Chem Lett; 2014 Jan; 24(1):360-6. PubMed ID: 24287382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
    Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
    FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.
    Stokes SS; Huynh H; Gowravaram M; Albert R; Cavero-Tomas M; Chen B; Harang J; Loch JT; Lu M; Mullen GB; Zhao S; Liu CF; Mills SD
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4556-60. PubMed ID: 21719282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds.
    Jahić H; Liu CF; Thresher J; Livchak S; Wang H; Ehmann DE
    Biochem Pharmacol; 2012 Sep; 84(5):654-60. PubMed ID: 22743594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.
    Srivastava SK; Dube D; Kukshal V; Jha AK; Hajela K; Ramachandran R
    Proteins; 2007 Oct; 69(1):97-111. PubMed ID: 17557328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
    Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
    Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.
    Mills SD; Eakin AE; Buurman ET; Newman JV; Gao N; Huynh H; Johnson KD; Lahiri S; Shapiro AB; Walkup GK; Yang W; Stokes SS
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1088-96. PubMed ID: 21189350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds.
    Bi F; Ma R; Ma S
    Curr Pharm Des; 2017; 23(14):2117-2130. PubMed ID: 27784238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic dihydrobenzoxazepine and tetracyclic indole derivatives can specifically target bacterial DNA ligases and can distinguish them from human DNA ligase I.
    Yadav N; Khanam T; Shukla A; Rai N; Hajela K; Ramachandran R
    Org Biomol Chem; 2015 May; 13(19):5475-87. PubMed ID: 25875403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of NAD(+) -dependent DNA ligase of mycobacteria as a potential target for antibiotics.
    Korycka-Machala M; Rychta E; Brzostek A; Sayer HR; Rumijowska-Galewicz A; Bowater RP; Dziadek J
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2888-97. PubMed ID: 17548501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-ones.
    Wang T; Duncan L; Gu W; O'Dowd H; Wei Y; Perola E; Parsons J; Gross CH; Moody CS; Arends SJ; Charifson PS
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3699-703. PubMed ID: 22560470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides.
    Gu W; Wang T; Maltais F; Ledford B; Kennedy J; Wei Y; Gross CH; Parsons J; Duncan L; Arends SJ; Moody C; Perola E; Green J; Charifson PS
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3693-8. PubMed ID: 22560473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureus.
    Kaczmarek FS; Zaniewski RP; Gootz TD; Danley DE; Mansour MN; Griffor M; Kamath AV; Cronan M; Mueller J; Sun D; Martin PK; Benton B; McDowell L; Biek D; Schmid MB
    J Bacteriol; 2001 May; 183(10):3016-24. PubMed ID: 11325928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel Inhibitors of
    Alomari A; Gowland R; Southwood C; Barrow J; Bentley Z; Calvin-Nelson J; Kaminski A; LeFevre M; Callaghan AJ; Vincent HA; Gowers DM
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of bacterial NAD⁺-dependent DNA ligase inhibitors: improvements in clearance of adenosine series.
    Stokes SS; Gowravaram M; Huynh H; Lu M; Mullen GB; Chen B; Albert R; O'Shea TJ; Rooney MT; Hu H; Newman JV; Mills SD
    Bioorg Med Chem Lett; 2012 Jan; 22(1):85-9. PubMed ID: 22154350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific and potent inhibition of NAD+-dependent DNA ligase by pyridochromanones.
    Brötz-Oesterhelt H; Knezevic I; Bartel S; Lampe T; Warnecke-Eberz U; Ziegelbauer K; Häbich D; Labischinski H
    J Biol Chem; 2003 Oct; 278(41):39435-42. PubMed ID: 12867414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis.
    Singh V; Somvanshi P
    Protein Pept Lett; 2010 Feb; 17(2):269-76. PubMed ID: 20214650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR development.
    Murphy-Benenato KE; Gingipalli L; Boriack-Sjodin PA; Martinez-Botella G; Carcanague D; Eyermann CJ; Gowravaram M; Harang J; Hale MR; Ioannidis G; Jahic H; Johnstone M; Kutschke A; Laganas VA; Loch JT; Miller MD; Oguto H; Patel SJ
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5172-7. PubMed ID: 26463129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor.
    Dwivedi N; Dube D; Pandey J; Singh B; Kukshal V; Ramachandran R; Tripathi RP
    Med Res Rev; 2008 Jul; 28(4):545-68. PubMed ID: 18080330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Base-modified NAD and AMP derivatives and their activity against bacterial DNA ligases.
    Pergolizzi G; Cominetti MM; Butt JN; Field RA; Bowater RP; Wagner GK
    Org Biomol Chem; 2015 Jun; 13(22):6380-98. PubMed ID: 25974621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.